ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 131 filers reported holding ACCELERON PHARMA INC in Q2 2017. The put-call ratio across all filers is 4.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $220,000 | -6.0% | 1,750 | -69.2% | 0.20% | +29.0% |
| Q2 2019 | $234,000 | -34.5% | 5,685 | -37.7% | 0.16% | +78.2% |
| Q1 2018 | $357,000 | -68.3% | 9,118 | -69.8% | 0.09% | -72.7% |
| Q3 2017 | $1,127,000 | +159.1% | 30,200 | +111.2% | 0.32% | +112.7% |
| Q2 2017 | $435,000 | -13.0% | 14,300 | -24.3% | 0.15% | -26.5% |
| Q1 2017 | $500,000 | – | 18,900 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 2 | $358 | 0.00% |